home / stock / atai / atai news


ATAI News and Press, ATAI Life Sciences N.V. From 06/21/22

Stock Information

Company Name: ATAI Life Sciences N.V.
Stock Symbol: ATAI
Market: NASDAQ
Website: atai.life

Menu

ATAI ATAI Quote ATAI Short ATAI News ATAI Articles ATAI Message Board
Get ATAI Alerts

News, Short Squeeze, Breakout and More Instantly...

ATAI - The Bulls Are Running in Psychedelic Stocks

The stock market has been tough over the last month, as has most of the U.S. economy. The Federal Reserve raised interest rates by 0.75 percent on Wednesday, June 15, and that reduces the amount of money in the economy. Besides mortgages, rising interest rates impact...

ATAI - Stephen Bardin to join atai Life Sciences as CFO Designate

atai Life Sciences (NASDAQ:ATAI) announced Stephen Bardin appionted as the as the CFO during the 3Q22. Initially, Mr. Bardin will join the company as Deputy CFO and CFO Designate on June 27th and will be supported in his transition by current CFO Greg Weaver. Mr....

ATAI - Stephen Bardin to Join atai Life Sciences as CFO Designate

Stephen Bardin will join as CFO Designate on June 27, 2022 After a transition period, atai’s current CFO Greg Weaver will be moving into a part time strategic advisory role NEW YORK and BERLIN, June 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V., (Nasdaq: ATAI) (&#x...

ATAI - atai Life Sciences to Participate in Upcoming June Healthcare Conferences

NEW YORK and BERLIN, June 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming healthcare conferences in...

ATAI - Are Psychedelics Still too Risky an Investment?

Editors Note: This story was originally published on June 13, but due to some technical problems we had to reset the website and as a result, the story got erased. This is the same story but republished. Biotechnology is always a dicey business to create, run, and make p...

ATAI - Measuring Psychedelic Investing Risk

Biotechnology is always a dicey business to create, run, and make profitable. Psychedelics add a difficulty factor of 10 to that equation. Currently, there are many psychedelic companies still working their compound through clinical trials—with no actual product to ma...

ATAI - Atai Life Sciences N.V.: A First Take

Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. The company’s approach of identifying (in many instances psychedelic) compounds that have been tested in previous hu...

ATAI - Atai Life Sciences And The Future Of Psychedelics For Mental Health

ATAI has a large portfolio of drugs, mainly psychedelics, that can be used to treat mental health conditions when other options have failed. There is ample room for new drug developments in this space, given that R&D for new drug developments has been declining. Success depend...

ATAI - Best Penny Stocks To Buy? 3 With Unusual Options Activity Today

When it comes to unusual options activity, Reddit, Twitter, and even stock market chat rooms seem to love this data. There are unusual options activity scanners that you can use to find stocks with irregular volume in their options chains. There are also websites like ours that scour throug...

ATAI - atai Life Sciences' (ATAI) CEO Florian Brand on Q1 2022 Results - Earnings Call Transcript

atai Life Sciences N.V. (ATAI) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Greg Weaver – Chief Financial Officer Florian Brand – Chief Executive Officer Srini Rao – Chief Scientific Officer Conference Call Participants Charles Duncan ...

Previous 10 Next 10